InvestorsHub Logo
Followers 588
Posts 47438
Boards Moderated 1
Alias Born 12/13/2007

Re: None

Thursday, 03/21/2024 8:33:37 AM

Thursday, March 21, 2024 8:33:37 AM

Post# of 487
Double digit stock eoy or sooner: Initiated IND-enabling studies for ABS-101, a potential best-in-class anti-TL1A antibody
Entered into collaboration with AstraZeneca for up to $247M in deal value, plus royalties

Strengthened balance sheet raising approximately $86M in gross proceeds through underwritten common stock offering
fyi ANT
Bullish
Bullish
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ABSI News